ANGELA SUREEN: Open Payments
NPI 1457762346 · WESTMINSTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,184 in 83 payments from 5 companies in 2025. Trend: 2023 $1,576 · 2024 $1,181 · 2025 $2,184
Food & beverage: $2,164Travel & lodging: $15Education: $5
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 49 | $1,197 |
| Janssen Pharmaceuticals, Inc | 13 | $384 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $290 |
| Neurocrine BioSciences, Inc. | 2 | $170 |
| Otsuka America Pharmaceutical, Inc. | 5 | $144 |
Products named: UZEDY, INVEGA SUSTENNA, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
